Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Parkinson’s disease is the second most common neurodegenerative disorder, characterised by progressive death of dopaminergic neurons in the substantia nigra. The prevalence of Parkinson’s disease is increasing and becoming a major health problem nowadays due to the aging of society. The aim of this study was to conduct a comprehensive review of the literature exploring the association between Parkinson’s disease and specific dietary components such as vitamin B12, omega-3 fatty acids, vitamin D, vitamin E, and probiotics. A literature search was performed in the medical database PubMed. Articles in English were retrieved. The impact of various nutritional ingredients on the occurrence, symptom severity, and progression of Parkinson’s disease was examined. An additional focus was on the underlying mechanisms, including oxidative stress and neuroinflammation, through which dietary components may exert their effects on the development of this disorder. Evidence suggests that early supplementation of vitamin B12 might mitigate cognitive dysfunction, omega-3 fatty acids may reduce disease progression, and probiotics may alleviate motor and non-motor symptoms, particularly constipation. In addition, vitamin D deficiency is common in patients with Parkinson’s disease. Furthermore, researchers have reported neuroprotective effects of vitamin E in animal studies, though human studies are inconclusive. Current research provides evidence that diet may influence the onset and course of Parkinson’s disease. A nutritional approach gives new possibilities regarding the prevention of the disorder. This review elucidates dietary interventions that may be considered as an adjunctive strategy in pharmacological therapies. However, further research on this topic is necessary.
Parkinson’s disease is the second most common neurodegenerative disorder, characterised by progressive death of dopaminergic neurons in the substantia nigra. The prevalence of Parkinson’s disease is increasing and becoming a major health problem nowadays due to the aging of society. The aim of this study was to conduct a comprehensive review of the literature exploring the association between Parkinson’s disease and specific dietary components such as vitamin B12, omega-3 fatty acids, vitamin D, vitamin E, and probiotics. A literature search was performed in the medical database PubMed. Articles in English were retrieved. The impact of various nutritional ingredients on the occurrence, symptom severity, and progression of Parkinson’s disease was examined. An additional focus was on the underlying mechanisms, including oxidative stress and neuroinflammation, through which dietary components may exert their effects on the development of this disorder. Evidence suggests that early supplementation of vitamin B12 might mitigate cognitive dysfunction, omega-3 fatty acids may reduce disease progression, and probiotics may alleviate motor and non-motor symptoms, particularly constipation. In addition, vitamin D deficiency is common in patients with Parkinson’s disease. Furthermore, researchers have reported neuroprotective effects of vitamin E in animal studies, though human studies are inconclusive. Current research provides evidence that diet may influence the onset and course of Parkinson’s disease. A nutritional approach gives new possibilities regarding the prevention of the disorder. This review elucidates dietary interventions that may be considered as an adjunctive strategy in pharmacological therapies. However, further research on this topic is necessary.
Parkinson’s disease (PD) is a neurodegenerative disorder that significantly impacts patients’ quality of life. Recent evidence has highlighted a complex relationship between the gut microbiota (GM) and PD. Understanding this relationship is crucial for potentially targeting GM in PD treatment and expanding therapeutic options. This study aimed to comprehensively analyze the global landscape, trends, and research focus on GM and PD using bibliometric analysis. Utilizing publications from the Web of Science Core Collection (WsSCC), bibliometric tools such as the R package ‘Bibliometrix,’ VOS viewer, and CiteSpace software were employed to assess parameters like yearly publications, countries/regions, institutions, and authors. Research trends and hotspots were identified through keyword analysis. The results revealed 1,161 articles published between 2013-2023, with China leading in publications (n=352, 30.31% of total), while the United States had a higher influence (H-index=58). The University of California System was the top institution in terms of publications (n=35), with the National Natural Science Foundation of China funding the most projects (n=172). Keshavarzian A and Sampson TR were the authors with the highest publication and co-citation counts, respectively. The International Journal of Molecular Sciences had the most articles published (n=48). Keyword analysis identified parkinson’s disease, gut microbiota, short-chain fatty acids, inflammation, and probiotics as main research topics. Biomarkers, ketogenic diet, and NF-κB were recent research hotspots and trends (2021-2023). The current study conducts an objective and comprehensive analysis of these publications, identifying trends and hotspots in the field of research. The findings offer valuable insights to scholars globally and in-vestigate potential therapeutic strategies for Parkinson’s Disease.
The human gut microbiome dysbiosis plays an important role in the pathogenesis of Parkinson’s disease (PD). The bidirectional relationship between the enteric nervous system (ENS) and central nervous system (CNS) under the mediation of the gut-brain axis control the gastrointestinal functioning. This review article discusses key mechanisms by which modifications in the composition and function of the gut microbiota (GM) influence PD progression and motor control loss. Increased intestinal permeability, chronic inflammation, oxidative stress, α-synuclein aggregation, and neurotransmitter imbalances are some key factors that govern gastrointestinal pathology and PD progression. The bacterial taxa of the gut associated with PD development are discussed with emphasis on the enteric nervous system (ENS), as well as the impact of gut bacteria on dopamine production and levodopa metabolism. The pathophysiology and course of the disease are associated with several inflammatory markers, including TNF-α, IL-1β, and IL-6. Emerging therapeutic strategies targeting the gut microbiome include probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation (FMT). The article explored how dietary changes may affect the gut microbiota (GM) and the ways that can affect Parkinson’s disease (PD), with a focus on nutrition-based, Mediterranean, and ketogenic diets. This comprehensive review synthesizes current evidence on the role of the gut microbiome in PD pathogenesis and explores its potential as a therapeutic target. Understanding these complex interactions may assist in the development of novel diagnostic tools and treatment options for this neurodegenerative disorder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.